As of 2024-12-11, the EV/EBITDA ratio of Theratechnologies Inc (TH.TO) is 9.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TH.TO's latest enterprise value is 126.22 mil CAD. TH.TO's TTM EBITDA according to its financial statements is 13.14 mil CAD. Dividing these 2 quantities gives us the above TH.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 12.4x | 10.6x |
| Forward P/E multiples | 9.7x - 18.5x | 14.1x |
| Fair Price | 2.91 - 6.82 | 4.36 |
| Upside | 36.2% - 218.9% | 103.7% |
| Date | EV/EBITDA |
| 2024-12-05 | 6.61 |
| 2024-12-04 | 6.44 |
| 2024-12-03 | 6.06 |
| 2024-12-02 | 5.99 |
| 2024-11-29 | 5.69 |
| 2024-11-28 | 5.69 |
| 2024-11-27 | 5.64 |
| 2024-11-26 | 5.79 |
| 2024-11-25 | 5.64 |
| 2024-11-22 | 5.61 |
| 2024-11-21 | 5.64 |
| 2024-11-20 | 5.69 |
| 2024-11-19 | 5.64 |
| 2024-11-18 | 5.71 |
| 2024-11-15 | 5.61 |
| 2024-11-14 | 5.64 |
| 2024-11-13 | 5.76 |
| 2024-11-12 | 5.79 |
| 2024-11-11 | 5.86 |
| 2024-11-08 | 5.89 |
| 2024-11-07 | 5.99 |
| 2024-11-06 | 5.86 |
| 2024-11-05 | 5.89 |
| 2024-11-04 | 5.66 |
| 2024-11-01 | 5.64 |
| 2024-10-31 | 5.66 |
| 2024-10-30 | 5.81 |
| 2024-10-29 | 5.71 |
| 2024-10-28 | 5.76 |
| 2024-10-25 | 5.86 |
| 2024-10-24 | 5.71 |
| 2024-10-23 | 5.99 |
| 2024-10-22 | 5.99 |
| 2024-10-21 | 6.14 |
| 2024-10-18 | 6.01 |
| 2024-10-17 | 5.84 |
| 2024-10-16 | 5.84 |
| 2024-10-15 | 5.81 |
| 2024-10-11 | 5.79 |
| 2024-10-10 | 5.81 |
| 2024-10-09 | 5.61 |
| 2024-10-08 | 5.51 |
| 2024-10-07 | 5.69 |
| 2024-10-04 | 5.56 |
| 2024-10-03 | 5.59 |
| 2024-10-02 | 5.59 |
| 2024-10-01 | 5.51 |
| 2024-09-30 | 5.66 |
| 2024-09-27 | 5.51 |
| 2024-09-26 | 5.64 |